16.45
Schlusskurs vom Vortag:
$16.30
Offen:
$16.37
24-Stunden-Volumen:
270.71K
Relative Volume:
0.63
Marktkapitalisierung:
$595.49M
Einnahmen:
$2.07M
Nettoeinkommen (Verlust:
$-47.68M
KGV:
-5.8333
EPS:
-2.82
Netto-Cashflow:
$-31.31M
1W Leistung:
+3.01%
1M Leistung:
+29.94%
6M Leistung:
+107.96%
1J Leistung:
+251.50%
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Vergleichen Sie DCTH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
DCTH
Delcath Systems Inc
|
16.45 | 595.49M | 2.07M | -47.68M | -31.31M | -2.82 |
![]()
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
![]()
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
![]()
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-06-28 | Eingeleitet | Craig Hallum | Buy |
2024-05-14 | Eingeleitet | Stephens | Overweight |
2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
2021-01-05 | Eingeleitet | BTIG Research | Buy |
2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
Delcath Systems: Strong Position In Metastatic Uveal Melanoma, But Broader Growth Challenges Ahead - Seeking Alpha
How should investors view Delcath Systems Inc (DCTH)? - US Post News
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc. - AOL
16,978 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Baader Bank Aktiengesellschaft - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Why You Should Keep An Eye On Delcath Systems - RTTNews
Where are the Opportunities in (DCTH) - Stock Traders Daily
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Biliary Tract Cancer Market Poised for Significant Growth from - openPR
Liver Cancer Treatment Pioneer Delcath Takes Center Stage at Elite Healthcare Summit - StockTitan
Rosalind Advisors, Inc. Expands Stake in Delcath Systems Inc. - GuruFocus.com
retail investors who own 58% along with institutions invested in Delcath Systems, Inc. (NASDAQ:DCTH) saw increase in their holdings value last week - Yahoo Finance
Delcath Systems, Inc. to Host Earnings Call - ACCESS Newswire
Delcath SystemsSuper Growth Projections - MSN
Delcath Systems (NASDAQ:DCTH) Hits New 1-Year HighTime to Buy? - MarketBeat
Barclays PLC Invests $104,000 in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems Stock Soars to 52-Week High of $15.7 Amidst Surge - Investing.com India
Sensus leads med-tech stock rebound in 2024, year closes with modest sector gain - BioWorld Online
When (DCTH) Moves Investors should Listen - Stock Traders Daily
Delcath Systems stock soars to 52-week high of $13.34 - MSN
Craig Hallum Raises Delcath Systems (NASDAQ:DCTH) Price Target to $21.00 - Defense World
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $21.00 - MarketBeat
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 31% Share Price Bounce - Simply Wall St
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Down 23.0% in December - Defense World
Delcath Systems stock retains Buy rating as Craig-Hallum raises price target by 17% - MSN
Delcath Systems stock soars to 52-week high of $13.34 By Investing.com - Investing.com Canada
Delcath Systems, Inc. (NASDAQ:DCTH) Sees Large Decrease in Short Interest - MarketBeat
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
Top 5 Small-cap Medical Device Stocks (Updated January 2025) - Investing News Network
Delcath Systems, Inc. (DCTH): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
Jane Street Group LLC Makes New Investment in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems, Inc. Releases Preliminary Financial Results and Updates Corporate Presentation - Defense World
Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why - Yahoo Finance
Delcath Systems (NASDAQ:DCTH) Earns Buy Rating from HC Wainwright - MarketBeat
Analyst Expectations For Delcath Systems's Future - Benzinga
Delcath Systems sees Q4 revenue $15.1M, consensus $12.42M - MSN
Biliary Tract Cancer Market Expected to Experience Major Growth - openPR
Delcath Systems Reports Strong 2024 Financial Performance - TipRanks
Delcath stock soars on Q4 and 2024 revenue beat By Investing.com - Investing.com Canada
Delcath stock soars on Q4 and 2024 revenue beat - Investing.com
Delcath reports preliminary Q4 and 2024 financials - Investing.com India
Delcath Systems Reports Strong Q4: $15.1M Revenue, HEPZATO Sales Drive 80%+ Margins - StockTitan
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):